Rebranding MS a dementia is top of the pops. #MSBlog #MSResearch
"Interesting that the Top 10 posts are also the most controversial and the most time intensive from my perspective; that is time spent preparing the post and time spent answering queries. There is a lesson in this. The "Rebranding MS a Dementia" post was meant to galvanise the MS community around the early highly-effective treat paradigm. It is great to note that the EMA has responded to the call. Let's hope NICE and other regulatory agencies do the same."
- Rebranding MS as a Dementia
- Biogen Idec delays BG12 launch in Europe
- Barriers to employment for MSers
- Good news: alemtuzumab gets a first-line license i...
- Adopting the HIV model
- There is no need to worry about pregnancy
- Cure for MS stopping the immune response
- Tysabri treatment blocks nerve loss and atrophy.
- Rebranding MS as a Dementia: part 2
- BG-12 Phase III Results: it is efficacious in subg...